{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T07:29:34Z","timestamp":1765006174493,"version":"3.46.0"},"reference-count":21,"publisher":"BMJ","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pathol"],"published-print":{"date-parts":[[1999,6]]},"abstract":"<jats:p>OBJECTIVES: To assess the feasibility of setting up a register of patients with asplenia within a defined geographical area; to ensure that guidelines on best practice were implemented; to obtain information on antibody levels to pneumococcal capsular polysaccharides and Haemophilus influenzae type b capsular polysaccharide, before and after immunisation and annually thereafter; to raise awareness of risks among clinicians and to offer advice on management. DESIGN: Prospective recruitment using multiple sources of recruitment. Annual follow up reminders sent from Registration Centre. SUBJECTS: Population of (old, pre-1995) Northern Health Region: approximately 3.1 million. MAIN OUTCOME MEASURES: Data were obtained on reasons for asplenia, duration of asplenia, use of prophylactic antibiotics, Medic-Alert bracelets, immunisations, antibody levels, death. RESULTS: The register was initiated at the beginning of April 1995 and ran to the end of March 1997. After two years of operation, 1111 cases had been registered but the response from some health districts was poor. Major primary causes of asplenia were trauma (264), other surgical (198), lymphoproliferative disease (154), and idiopathic thrombocytopenic purpura (147). There were 664 patients on prophylactic antibiotics, of whom 498 were on continuous antibiotics. Only 18 had any type of warning bracelet. Antibody measurements were carried out at least once on 75% of patients; 306 patients had satisfactory antibody levels on first blood sample in year 1, rising to 405 in year 2; 43 patients failed to make any antibody response to Pneumovax despite multiple immunisations, and three patients failed to respond to Hib vaccine. Sixteen patients with satisfactory antibody levels in year 1 had low levels in year 2 requiring vaccine boosters. Sixteen deaths were reported, two of which were directly attributable to overwhelming sepsis. CONCLUSIONS: Registration has been successful and has raised awareness of the management of asplenia. Compliance with antibiotic prophylaxis and immunisation was initially poor. A potential high risk group of vaccine non-responders has been identified and poor persistence of pneumococcal antibodies has been identified which is likely to alter approaches to immunisation in asplenic patients.<\/jats:p>","DOI":"10.1136\/jcp.52.6.424","type":"journal-article","created":{"date-parts":[[2008,12,31]],"date-time":"2008-12-31T19:05:02Z","timestamp":1230750302000},"page":"424-429","source":"Crossref","is-referenced-by-count":33,"title":["Northern region asplenia register--analysis of first two years."],"prefix":"10.1136","volume":"52","author":[{"given":"G P","family":"Spickett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Bullimore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Wallis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1999,6,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1136\/bmj.307.6916.1372","article-title":"Long term management of patients after splenectomy","volume":"307","author":"McMullin, M.; Johnston, G.","year":"1993","unstructured":"McMullin M, Johnston G. Long term management of patients after splenectomy. BMJ 1993;307:1372\u20133.","journal-title":"BMJ"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1365-2141.1993.tb03128.x","article-title":"Management of asplenic patients","volume":"84","author":"Lortan, J.E.","year":"1993","unstructured":"Lortan JE. Management of asplenic patients. Br J Haematol 1993;84:566\u20139.","journal-title":"Br J Haematol"},{"key":"ref_3","first-page":"165","article-title":"Protection for the asplenic patient","volume":"34","author":"Mayon-White, R.","year":"1994","unstructured":"Mayon-White R. Protection for the asplenic patient. Prescribers J 1994;34:165\u201370.","journal-title":"Prescribers J"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/jac\/33.1.4","article-title":"Finch RG. Prophylaxis after splenectomy","volume":"33","author":"Read RC","year":"1994","unstructured":"Read RC, Finch RG. Prophylaxis after splenectomy. J Antimicrob Chemother 1994;33:4\u20136.","journal-title":"J Antimicrob Chemother"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/bjs.1800780626","article-title":"Severe late postsplenectomy infection","volume":"78","author":"Cullingford, G.L.; Watkins, D.N.; Watts, A.D.J.","year":"1991","unstructured":"Cullingford GL, Watkins DN, Watts ADJ, et al. Severe late postsplenectomy infection. Br J Surg 1991;78:716\u201321.","journal-title":"Br J Surg"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/bjs.1800760528","article-title":"Incidence of septic and thromboembolic-related deaths after splenectomy in adults","volume":"76","author":"Pimpl, W.; Dapunt, O.; Kaindl, H.","year":"1989","unstructured":"Pimpl W, Dapunt O, Kaindl H, et al. Incidence of septic and thromboembolic-related deaths after splenectomy in adults. Br J Surg 1989;76:517\u201321.","journal-title":"Br J Surg"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/bjs.1800780904","article-title":"Postsplenectomy sepsis and its mortality rate: actual versus perceived risks","volume":"78","author":"Holdsworth, R.J.; Irving, A.D.; Cuschieri, A.","year":"1991","unstructured":"Holdsworth RJ, Irving AD, Cuschieri A. Postsplenectomy sepsis and its mortality rate: actual versus perceived risks. Br J Surg 1991;78:1031\u20138.","journal-title":"Br J Surg"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/jcp.38.3.309","article-title":"Postsplenectomy sepsis 10 or more years after operation","volume":"38","author":"Evans, D.","year":"1985","unstructured":"Evans D. Postsplenectomy sepsis 10 or more years after operation. J Clin Pathol 1985;38:309\u201311.","journal-title":"J Clin Pathol"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0140-6736(94)91635-7","article-title":"Splenectomy, sepsis, immunisation and guidelines","volume":"344","author":"Reid, M.M.","year":"1994","unstructured":"Reid MM. Splenectomy, sepsis, immunisation and guidelines. Lancet 1994;344:970\u20131.","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1136\/bmj.312.7028.430","article-title":"Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. Working Party of the British Committee for Standards in Haematology Clinical Haematology Task Force","volume":"312","author":"Party, Working","year":"1996","unstructured":"Working Party. Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. Working Party of the British Committee for Standards in Haematology Clinical Haematology Task Force. BMJ 1996;312:430\u20134.","journal-title":"BMJ"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/003693309604100107","article-title":"Overwhelming pneumococcal sepsis in two patients splenectomised more than ten years previously","volume":"41","author":"Hassan, I.S.; Snow, M.H.; Ong, E.L.","year":"1996","unstructured":"Hassan IS, Snow MH, Ong EL. Overwhelming pneumococcal sepsis in two patients splenectomised more than ten years previously. Scot Med J 1996;41:17\u201319.","journal-title":"Scot Med J"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/jcp.48.3.260","article-title":"Immunological factors and risk of infection in plateau phase myeloma","volume":"48","author":"Hargreaves, R.M.; Lea, JR, GriYths; H.","year":"1995","unstructured":"Hargreaves RM, Lea JR, GriYths H, et al. Immunological factors and risk of infection in plateau phase myeloma. J Clin Pathol 1995; 48:260\u20136.","journal-title":"J Clin Pathol"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1136\/adc.67.4.475","article-title":"Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunisation schedule","volume":"67","author":"Booy, R.; Taylor, S.A.; Dobson, S.R.M.","year":"1992","unstructured":"Booy R, Taylor SA, Dobson SRM, et al. Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunisation schedule. Arch Dis Child 1992;67:475\u20138.","journal-title":"Arch Dis Child"},{"key":"ref_14","first-page":"173","article-title":"Management of asplenic patients in South Buckinghamshire: an audit of local practice","volume":"5","author":"MacInnes, J.; Waghorn, D.J.; Haworth, E.","year":"1995","unstructured":"MacInnes J, Waghorn DJ, Haworth E. Management of asplenic patients in South Buckinghamshire: an audit of local practice. CDR Rev 1995;5:R173\u20137.","journal-title":"CDR Rev"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1017\/S0950268897007978","article-title":"Antibody levels against Streptococcus pneumoniae and Haemophilus influenzae type b in a population of splenectomised individuals with varying vaccination status","volume":"119","author":"Konradsen, H.B.; Rasmussen, C.; Ejstrud, P.","year":"1997","unstructured":"Konradsen HB, Rasmussen C, Ejstrud P, et al. Antibody levels against Streptococcus pneumoniae and Haemophilus influenzae type b in a population of splenectomised individuals with varying vaccination status. Epidemiol Infect 1997; 119:167\u201374.","journal-title":"Epidemiol Infect"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0022-3476(89)80607-9","article-title":"Impaired antibody response to polysaccharides in association with functional asplenia","volume":"114","author":"Gaines, A.D.; Buckley, R.H.","year":"1989","unstructured":"Gaines AD, Buckley RH. Impaired antibody response to polysaccharides in association with functional asplenia. J Pediatr 1989;114:89\u201391.","journal-title":"J Pediatr"},{"key":"ref_17","first-page":"402","article-title":"Immune status and response to immunisation with polysaccharide vaccines of a healthy congenitally asplenic woman. Clin Exp Immunol","volume":"78","author":"McElroy, P.J.; Henderson, F.I.; Brown, D.L.","year":"1989","unstructured":"McElroy PJ, Henderson FI, Brown DL. Immune status and response to immunisation with polysaccharide vaccines of a healthy congenitally asplenic woman. Clin Exp Immunol 1989;78:402\u20135."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0140-6736(78)90612-8","article-title":"Immune response after splenectomy","volume":"i:","author":"Sullivan, J.L.; Ochs, H.D.; SchiVman, G.","year":"1978","unstructured":"Sullivan JL, Ochs HD, SchiVman G, et al. Immune response after splenectomy. Lancet 1978;i:178\u201381.","journal-title":"Lancet"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/0003-4819-104-4-467","article-title":"Antibody response to pre-treatment immunisation and post-treatment boosting with bacterial polysaccharide vaccines in patients with Hodgkin\u2019s disease","volume":"104","author":"Siber, G.R.; Gorham, C.; Marten, P.","year":"1980","unstructured":"Siber GR, Gorham C, Marten P, et al. Antibody response to pre-treatment immunisation and post-treatment boosting with bacterial polysaccharide vaccines in patients with Hodgkin\u2019s disease. Ann Intern Med 1980;104:467\u201375.","journal-title":"Ann Intern Med"},{"key":"ref_20","first-page":"279","article-title":"Pneumococcal antibody levels one decade after immunisation of healthy adults","volume":"293","author":"Mufson, M.A.; Krause, H.E.; SchiVman, G.","year":"1987","unstructured":"Mufson MA, Krause HE, SchiVman G, et al. Pneumococcal antibody levels one decade after immunisation of healthy adults. Am J Med Sci 1987;293:279\u201384.","journal-title":"Am J Med Sci"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/00006454-199004000-00007","article-title":"Pneumococcal vaccination of splenectomised children","volume":"9","author":"Konradsen, H.B.; Pederson, F.K.; Henrichsen, J.","year":"1990","unstructured":"Konradsen HB, Pederson FK, Henrichsen J. Pneumococcal vaccination of splenectomised children. Pediatr Infect Dis J 1990;9:258\u201363.","journal-title":"Pediatr Infect Dis J"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jcp.52.6.424","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T07:26:09Z","timestamp":1765005969000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jcp.52.6.424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,6]]},"references-count":21,"journal-issue":{"issue":"6","published-online":{"date-parts":[[1999,6,1]]},"published-print":{"date-parts":[[1999,6]]}},"alternative-id":["10.1136\/jcp.52.6.424"],"URL":"https:\/\/doi.org\/10.1136\/jcp.52.6.424","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"type":"print","value":"0021-9746"},{"type":"electronic","value":"1472-4146"}],"subject":[],"published":{"date-parts":[[1999,6]]}}}